Champions Oncology (CSBR) Return on Invested Capital (2011 - 2026)

Champions Oncology's Return on Invested Capital history runs 16 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital fell 3.0% year-over-year to 0.01%; the TTM figure through Jan 2026 stood at 0.01% (down 3.0% YoY), while the FY2025 annual figure was 0.05%, up 10.0% from the prior year.
• Return on Invested Capital was 0.01% for Q1 2026 at Champions Oncology, down from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.1% in Q1 2024 to a low of 0.1% in Q4 2023.
• Historically, Return on Invested Capital has averaged 0.0% across 5 years, with a median of 0.0% in 2022.
• The sharpest annual moves came in 2023 and 2024: Return on Invested Capital decreased 10 bps in 2023, then rose 10 bps in 2024.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then sank by 49347 bps to 0.1% in 2023, then soared by 56 bps to 0.04% in 2024, then jumped by 113 bps to 0.01% in 2025, then plunged by 206 bps to 0.01% in 2026.
• The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.